NGL Fine-Chem Limited Share Price & Analysis
₹2610.60−0.83%Updated 28 Oct 2026, 03:30 pm IST
LTP
₹2610.60−0.83%Open
₹2611.00High
₹2664.80Low
₹2598.00Close
₹2610.6052W High
₹3602.0052W Low
₹1261.00Volume
3KLot Size
1Sector
HealthcareMarket Cap
₹2K CrFace Value
₹5Small Cap
Price Chart
Candle
Range
Fundamentals
P/E
28.60Sector P/E
50.20P/B
4.98EPS
₹77.82ROE
17.40%ROCE
18.60%D/E Ratio
0.33Div Yield
0.07%Book Value
₹533.00Strengths
- Strong return on equity (ROE 17.4%)
- Efficient capital deployment (ROCE 18.6%)
- Attractively valued vs sector (P/E 28.6x vs industry 50.2x)
- Low debt relative to equity (D/E 0.3x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
NGLFINE · as of Mar 2026
Promoters72.74%
Public27.26%0.03pp
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 73.06% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% |
| FII | 0.04% | 0.10% | 0.03% | 0.02% | 0.05% | — |
| Public | 26.91% | 27.16% | 27.24% | 27.25% | 27.23% | 27.26% |
Latest News
All newsNGL Fine-Chem receives SEBI exemption order
*NGL Fine-Chem receives SE bidi exemption order* from SEBI under SAST regulations. The exemption pertains to **Regulation 11(5)**, enabling smoother share acquisition compliance. No immediate financial impact is indicated. This is a procedural regulatory update. 📊 *STOCKS:* $NGLFL | 🏢 *SECTOR:* Pharma | #LOWIMPACT #SEBI
NSE Filing13 Oct
NGL Fine-Chem shares may react to investor meet updates
*NGL Fine-Chem shares may react to investor meet updates*. The company shared outcomes from its recent Analyst/Institutional Investor meet via a stock exchange filing. No major financial figures or strategic shifts were disclosed. The update is primarily informational in nature. 📊 *STOCKS:* $NGLFL | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet
NSE Filing16 Sept
NGL Fine-Chem publishes mandatory newspaper notice
*NGL Fine-Chem publishes mandatory newspaper notice*. NGL Fine-Chem Limited has informed the stock exchange about a copy of a newspaper publication, as part of regulatory compliance. Such disclosures are routine and do not indicate any operational or financial change. No financial impact is expected from this filing. 📊 *STOCKS:* $NGLFL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #CorporateFiling
NSE Filing14 Aug
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹128 Cr 6.7% | ₹120 Cr 15.4% | ₹104 Cr 9.5% | ₹95 Cr 6.7% | ₹89 Cr 4.3% | ₹93 Cr 2.2% | ₹91 Cr 9.0% | ₹100 Cr |
| Op. Profit | ₹22 Cr 29.4% | ₹17 Cr 54.5% | ₹11 Cr 83.3% | ₹6 Cr 20.0% | ₹5 Cr 58.3% | ₹12 Cr 33.3% | ₹9 Cr 43.8% | ₹16 Cr |
| OPM | 18.0% 28.6% | 14.0% 27.3% | 11.0% 57.1% | 7.0% 16.7% | 6.0% 50.0% | 12.0% 20.0% | 10.0% 37.5% | 16.0% |
| Net Profit | ₹16 Cr 60.0% | ₹10 Cr 11.1% | ₹9 Cr 800.0% | ₹1 Cr 0.0% | ₹1 Cr 90.0% | ₹10 Cr 11.1% | ₹9 Cr 25.0% | ₹12 Cr |
| EPS (₹) | 25.4 62.9% | 15.59 4.2% | 14.96 1619.5% | 0.87 58.0% | 2.07 87.0% | 15.88 6.4% | 14.92 25.2% | 19.94 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹368 Cr 8.6% | ₹339 Cr 21.9% | ₹278 Cr 12.6% | ₹318 Cr 23.3% | ₹258 Cr 69.7% | ₹152 Cr 0.7% | ₹153 Cr |
| Expenses | ₹333 Cr 16.8% | ₹285 Cr 17.3% | ₹243 Cr 2.4% | ₹249 Cr 39.9% | ₹178 Cr 36.9% | ₹130 Cr 7.4% | ₹121 Cr |
| Op. Profit | ₹35 Cr 35.2% | ₹54 Cr 54.3% | ₹35 Cr 48.5% | ₹68 Cr 15.0% | ₹80 Cr 263.6% | ₹22 Cr 31.3% | ₹32 Cr |
| OPM | 9.0% 43.8% | 16.0% 23.1% | 13.0% 38.1% | 21.0% 32.3% | 31.0% 121.4% | 14.0% 33.3% | 21.0% |
| Other Income | ₹9 Cr 35.7% | ₹14 Cr 133.3% | ₹6 Cr 45.5% | ₹11 Cr 37.5% | ₹8 Cr 700.0% | ₹1 Cr 75.0% | ₹4 Cr |
| Interest | ₹3 Cr 50.0% | ₹2 Cr 0.0% | ₹2 Cr 0.0% | ₹2 Cr 0.0% | ₹2 Cr 33.3% | ₹3 Cr 0.0% | ₹3 Cr |
| Depreciation | ₹12 Cr 0.0% | ₹12 Cr 9.1% | ₹11 Cr 10.0% | ₹10 Cr 25.0% | ₹8 Cr 0.0% | ₹8 Cr 33.3% | ₹6 Cr |
| PBT | ₹28 Cr 48.1% | ₹54 Cr 100.0% | ₹27 Cr 59.7% | ₹67 Cr 14.1% | ₹78 Cr 550.0% | ₹12 Cr 57.1% | ₹28 Cr |
| Tax % | 24.0% 0.0% | 24.0% 4.0% | 25.0% 0.0% | 25.0% 7.4% | 27.0% 12.9% | 31.0% 14.8% | 27.0% |
| Net Profit | ₹21 Cr 48.8% | ₹41 Cr 105.0% | ₹20 Cr 60.0% | ₹50 Cr 12.3% | ₹57 Cr 612.5% | ₹8 Cr 60.0% | ₹20 Cr |
| EPS (₹) | 34.19 48.9% | 66.88 101.6% | 33.18 58.9% | 80.77 12.0% | 91.81 580.1% | 13.5 58.6% | 32.58 |
| Div Payout | 5.0% 66.7% | 3.0% 40.0% | 5.0% 150.0% | 2.0% 0.0% | 2.0% 84.6% | 13.0% 160.0% | 5.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
Liabilities | ||||||||
| Equity Capital | ₹3 Cr 0.0% | ₹3 Cr 0.0% | ₹3 Cr 0.0% | ₹3 Cr 0.0% | ₹3 Cr 0.0% | ₹3 Cr 0.0% | ₹3 Cr 0.0% | ₹3 Cr |
| Reserves | ₹297 Cr 6.5% | ₹279 Cr 7.3% | ₹260 Cr 18.7% | ₹219 Cr 9.5% | ₹200 Cr 32.5% | ₹151 Cr 57.3% | ₹96 Cr 7.9% | ₹89 Cr |
| Borrowings | ₹88 Cr 14.3% | ₹77 Cr 126.5% | ₹34 Cr 6.3% | ₹32 Cr 6.7% | ₹30 Cr 87.5% | ₹16 Cr 42.9% | ₹28 Cr 3.7% | ₹27 Cr |
| Other Liabilities | ₹96 Cr 29.7% | ₹74 Cr 25.4% | ₹59 Cr 84.4% | ₹32 Cr 27.3% | ₹44 Cr 22.2% | ₹36 Cr 38.5% | ₹26 Cr 13.0% | ₹23 Cr |
| Total Liabilities | ₹484 Cr 11.8% | ₹433 Cr 21.6% | ₹356 Cr 24.0% | ₹287 Cr 3.6% | ₹277 Cr 33.8% | ₹207 Cr 34.4% | ₹154 Cr 8.5% | ₹142 Cr |
Assets | ||||||||
| Fixed Assets | ₹170 Cr 18.9% | ₹143 Cr 66.3% | ₹86 Cr 2.3% | ₹88 Cr 1.1% | ₹89 Cr 39.1% | ₹64 Cr 5.9% | ₹68 Cr 11.5% | ₹61 Cr |
| CWIP | ₹35 Cr 30.0% | ₹50 Cr 8.7% | ₹46 Cr 76.9% | ₹26 Cr 333.3% | ₹6 Cr 50.0% | ₹12 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹49 Cr 18.3% | ₹60 Cr 11.1% | ₹54 Cr 38.5% | ₹39 Cr 34.5% | ₹29 Cr 0.0% | ₹29 Cr 163.6% | ₹11 Cr 22.2% | ₹9 Cr |
| Other Assets | ₹230 Cr 27.1% | ₹181 Cr 5.8% | ₹171 Cr 28.6% | ₹133 Cr 13.1% | ₹153 Cr 50.0% | ₹102 Cr 36.0% | ₹75 Cr 2.7% | ₹73 Cr |
| Total Assets | ₹484 Cr 11.8% | ₹433 Cr 21.6% | ₹356 Cr 24.0% | ₹287 Cr 3.6% | ₹277 Cr 33.8% | ₹207 Cr 34.4% | ₹154 Cr 8.5% | ₹142 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹36 Cr 80.0% | ₹20 Cr 42.9% | ₹35 Cr 150.0% | ₹14 Cr 48.1% | ₹27 Cr 35.0% | ₹20 Cr 122.2% | ₹9 Cr |
| Investing CF | ₹-35 Cr 29.6% | ₹-27 Cr 0.0% | ₹-27 Cr 92.9% | ₹-14 Cr 44.0% | ₹-25 Cr 25.0% | ₹-20 Cr 100.0% | ₹-10 Cr |
| Financing CF | ₹-1 Cr 0.0% | ₹-1 Cr 0.0% | ₹-1 Cr 0.0% | ₹-1 Cr 0.0% | ₹-1 Cr 0.0% | ₹-1 Cr | ₹0 Cr |
| Net Cash Flow | ₹0 Cr 100.0% | ₹-7 Cr 200.0% | ₹7 Cr 800.0% | ₹-1 Cr 150.0% | ₹2 Cr | ₹0 Cr 100.0% | ₹-1 Cr |
| Free Cash Flow | ₹-38 Cr 375.0% | ₹-8 Cr 260.0% | ₹5 Cr 133.3% | ₹-15 Cr 250.0% | ₹10 Cr 66.7% | ₹6 Cr 200.0% | ₹-6 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 81d 16.5% | 97d 12.8% | 86d 16.2% | 74d 39.6% | 53d 15.9% | 63d 20.3% | 79d |
| Inventory Days | 101d 3.1% | 98d 42.0% | 69d 49.6% | 137d 3.8% | 132d 14.8% | 155d 46.2% | 106d |
| Days Payable | 113d 0.9% | 112d 77.8% | 63d 30.8% | 91d 11.7% | 103d 11.2% | 116d 26.1% | 92d |
| Cash Conv. Cycle | 68d 18.1% | 83d 10.8% | 93d 22.5% | 120d 46.3% | 82d 19.6% | 102d 9.7% | 93d |
| Working Capital Days | 50d 34.2% | 76d 11.8% | 68d 24.4% | 90d 30.4% | 69d 19.0% | 58d 17.1% | 70d |
| ROCE | 9.0% 55.0% | 20.0% 66.7% | 12.0% 64.7% | 34.0% 37.0% | 54.0% 285.7% | 14.0% | — |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is NGL Fine-Chem Limited share price today?
NGL Fine-Chem Limited (NGLFINE) is currently trading at ₹2,610.6 on NSE, down 0.83% as of the last market session. Prices update daily after market close on MarketNetra.
Is NGL Fine-Chem Limited available in F&O (Futures & Options)?
Yes, NGL Fine-Chem Limited (NGLFINE) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is NGL Fine-Chem Limited 52-week high and low?
NGL Fine-Chem Limited's 52-week high is ₹3,602 and the 52-week low is ₹1,261. The current price of ₹2,610.6 is 27.5% below the 52W high.
What is NGL Fine-Chem Limited P/E ratio?
NGL Fine-Chem Limited's current P/E ratio is 28.6. This indicates the market is paying ₹28.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade NGL Fine-Chem Limited options?
NGL Fine-Chem Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade NGLFINE options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.